asset_category:
peer_benchmark:
broad_market_index:
manager_contact_details: Array
ticker: CD3
release_schedule:
structure: Listed Investment Company
commentary_block:
factsheet_url:
fund_features:
Cordish Dixon Private Equity Fund III (CD3) was listed on the ASX in July 2016 after raising $76.8m and is the third listed investment trust in the series. An additional $36.5m was raised in September 2017 via an offer of new units. The Trust invests in a fund that invests in an underlying portfolio of boutique private equity funds in the US. The Investment Manager has appointed an Advisory Board to assist with the investment selection. Given the underlying funds are based in the US, investors will be subject to foreign exchange movements.
- CD3 does not intend to hedge the currency exposure, but has the right if it so decides.
- The portfolio is fully committed to 13 private investment funds.
- The underlying investments will charge a management fee on the capital committed and a performance fee. The Fund will return capital via the payment of distributions when the underlying funds exit investments.
- The Trust seeks to provide Australian investors access to a portfolio of boutique US private equity investments, offering a family office style of investing, a style of investment typically not available to retail investors.